Z
Zenas BioPharma, Inc.
ZBIO · NASDAQ · Healthcare · 1.9B
Closing price
$27.26
+3.89% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
5.0×
Enterprise value / EBITDAEV/EBITDA
-3.2×
Free cash flow yieldFCF yield
-14.1%
Return on equityROE
-156.0%
Operating margin
-2113.8%
Net debt / EBITDAbalance-sheet strength
0.1×
Interest coverage
-28.9×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.